Erector spinae plane block for managing pain after breast cancer surgery
Official title: Impact of Erector Spinae Plane Block With Adjuvant Dexmedetomidine on Chronic Postsurgical Pain in Breast Cancer Patients: a Two-center Randomized Controlled Trial
Run by Peking University First Hospital · NCT05494502 · Data updated 2026-11-12
This study is testing if a special nerve block combined with a medication can help reduce pain and improve recovery for women after breast cancer surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 1206 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 2 sites (Beijing, Beijing Municipality and 1 other locations) |
| Status | Recruiting |
| Started | May 23, 2023 |
| Main results expected | November 2025 |
| Study ends | July 2027 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT05494502 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 85 scheduled for unilateral mastectomy due to primary breast cancer.
✕Probably not a fit
Patients with previous breast surgeries, chronic opioid dependence, or contraindications to the erector spinae plane block will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of the erector spinae plane block (ESPB) combined with dexmedetomidine in reducing chronic postsurgical pain (CPSP) in breast cancer patients undergoing mastectomy. The study aims to determine if this nerve block technique can improve pain management and enhance the quality of life for patients post-surgery. Participants will be randomly assigned to receive either the ESPB intervention or standard care, with outcomes measured over time to assess pain levels and overall recovery. The trial builds on previous findings that suggest regional anesthesia may help prevent CPSP and improve long-term outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of chronic pain in breast cancer patients after surgery, improving their quality of life.
How similar studies have gone: Previous studies have shown promising results with similar nerve block techniques in reducing chronic pain after breast surgery, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age of 18 years or over, but less than 85 years; 2. Scheduled to undergo mastectomy for primary unilateral breast cancer. Exclusion Criteria: 1. Previous breast cancer surgery with an incision of \>2 cm; 2. Chronic opioid dependence or long-term intake of analgesic medicines (\>3 months); 3. Any contraindication to erector spinae plane block, including intrathoracic infection, infection at the puncture site, cancer invasion of the puncture site, severe spinal deformity, history of spinal surgery, and severe coagulopathy; 4. Inability to communicate in the preoperative period because of profound dementia, deafness, language barriers, or end-stage disease; 5. History of malignant tumor in other organs, or a current combination of malignant tumor of other organs; 6. History of coronary heart disease (diagnosed coronary stenosis, previous myocardial infarction, previous percutaneous coronary intervention or coronary artery bypass grafting); preoperative hepatic or renal impairment (alanine transaminase and/or aspartate transaminase ≥2 times of upper limit of normal, or serum creatinine\>133 µmol/L); history of peptic ulcer or hemorrhage; ASA classification IV or above; 7. Allergy to ropivacaine.
Where it's running
-
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting -
Beijing Cancer Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Dong-Xin Wang, M.D., Ph.D. — Peking University First Hospital
- Study coordinator: Qiongfang Wu, M.D.
- Email: wuqf91@163.com
- Phone: +8618310161109
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing dexmedetomidine and lidocaine for pain management after mastectomy
This study is testing whether dexmedetomidine or lidocaine works better for managing pain after mastectomy surgery in adults aged 18 to 75.
-
Transverse vs Longitudinal Serratus Anterior Plane Block for Breast Surgery
This trial tests whether a longitudinal ultrasound view for serratus anterior plane block provides better pain relief after breast surgery than the standard transverse view.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Bupivacaine plus lidocaine versus bupivacaine alone for ultrasound-guided popliteal sciatic nerve block
This trial will test whether adding lidocaine to bupivacaine gives faster numbness and longer-lasting pain relief for adults having below-knee (foot or ankle) surgery with an ultrasound-guided popliteal sciatic nerve block.
-
Comparing two ultrasound-guided chest wall nerve blocks for pain after mastectomy
This study will see if one of two ultrasound-guided chest wall nerve blocks gives better pain relief and less opioid use for women having an elective mastectomy.
-
PENG block plus local infiltration analgesia for anterior-approach hip replacement
This test sees if a motor-sparing PENG block combined with local infiltration around the hip controls pain as well as spinal anesthesia for adults having anterior‑approach hip replacement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.